Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists.
暂无分享,去创建一个
V. Ananthanarayanan | B S Zhorov | E V Folkman | V S Ananthanarayanan | B. Zhorov | E. Folkman | Ekaterina V. Folkman
[1] C. Armstrong. Interaction of Tetraethylammonium Ion Derivatives with the Potassium Channels of Giant Axons , 1971, The Journal of general physiology.
[2] H. Glossmann,et al. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit. , 1995, Biochemistry.
[3] E. Mccleskey,et al. Ion Channel Selectivity through Stepwise Changes in Binding Affinity , 1998, The Journal of general physiology.
[4] B. Eisenberg,et al. Binding and selectivity in L-type calcium channels: a mean spherical approximation. , 2000, Biophysical journal.
[5] R. Kass,et al. Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor , 1989, The Journal of general physiology.
[6] W. Catterall,et al. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. , 1994, Science.
[7] W. Catterall,et al. Molecular determinants of drug binding and action on L-type calcium channels. , 1997, Annual review of pharmacology and toxicology.
[8] S. Cannon,et al. Rapid and slow voltage-dependent conformational changes in segment IVS6 of voltage-gated Na(+) channels. , 2000, Biophysical journal.
[9] Y. Kwan,et al. Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site. , 1995, Journal of molecular and cellular cardiology.
[10] V. Ananthanarayanan,et al. Structural model of a synthetic Ca2+ channel with bound Ca2+ ions and dihydropyridine ligand. , 1996, Biophysical journal.
[11] E. Perozo,et al. Structural rearrangements underlying K+-channel activation gating. , 1999, Science.
[12] Y. Mori,et al. Structural determinants of ion selectivity in brain calcium channel , 1993, FEBS letters.
[13] C. Strübing,et al. Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels , 1993, British journal of pharmacology.
[14] A. Schwartz,et al. Motif III S5 of L-type Calcium Channels Is Involved in the Dihydropyridine Binding Site , 1997, The Journal of Biological Chemistry.
[15] Sheryl E. Koch,et al. Molecular elements of ion permeation and selectivity within calcium channels. , 1999, Critical reviews in biochemistry and molecular biology.
[16] D. Triggle,et al. Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists. , 2000, Journal of medicinal chemistry.
[17] S. Y. Wang,et al. Local anesthetic block of batrachotoxin-resistant muscle Na+ channels. , 1998, Molecular pharmacology.
[18] M. Nakasako,et al. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution , 2000, Nature.
[19] R. Tsien,et al. Molecular basis of proton block of L-type Ca2+ channels , 1996, The Journal of general physiology.
[20] A. Bahinski,et al. Differential contribution by conserved glutamate residues to an ion‐selectivity site in the L‐type Ca2+ channel pore , 1993, FEBS letters.
[21] Gary Yellen,et al. The bacterial K+ channel structure and its implications for neuronal channels , 1999, Current Opinion in Neurobiology.
[22] S. Y. Wang,et al. Residues in Na(+) channel D3-S6 segment modulate both batrachotoxin and local anesthetic affinities. , 2000, Biophysical journal.
[23] S. Y. Wang,et al. Batrachotoxin-resistant Na+ channels derived from point mutations in transmembrane segment D4-S6. , 1999, Biophysical journal.
[24] Ruiping Huang,et al. Poly-3-hydroxybutyrate/polyphosphate complexes form voltage-activated Ca2+ channels in the plasma membranes of Escherichia coli. , 1995, Biophysical journal.
[25] U. Singh,et al. A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .
[26] K. Itagaki,et al. Identification of 1,4‐dihydropyridine binding domains within the primary structure of the α1 subunit of the skeletal muscle L‐type calcium channel , 1993, FEBS letters.
[27] Y. Okamura,et al. Serine Residue in the IIIS5-S6 Linker of the L-type Ca2+ Channel α1C Subunit Is the Critical Determinant of the Action of Dihydropyridine Ca2+Channel Agonists* , 2000, The Journal of Biological Chemistry.
[28] R. Wagner,et al. Exploring the open pore of the potassium channel from Streptomyces lividans , 1999, FEBS letters.
[29] H. Guy,et al. A putative prokaryote voltage-gated Ca(2+) channel with only one 6TM motif per subunit. , 2001, Biochemical and biophysical research communications.
[30] W. Catterall,et al. Receptor sites for Ca2+ channel antagonists. , 1992, Trends in pharmacological sciences.
[31] N. Klugbauer,et al. Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels. , 1997, Circulation research.
[32] Boris S. Zhorov,et al. A vector method for calculating the derivatives of the energy of the atom-atom interactions of complex molecules with respect to generalized coordinates , 1981 .
[33] H. Fozzard,et al. KcsA crystal structure as framework for a molecular model of the Na(+) channel pore. , 2000, Biochemistry.
[34] T. Langer,et al. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. , 2000, The Biochemical journal.
[35] R. Kass,et al. Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium , 1991, The Journal of general physiology.
[36] R. Kass,et al. L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines. , 1994, Molecular Pharmacology.
[37] R. Tsien,et al. Ca2+ channel selectivity at a single locus for high-affinity Ca2+ interactions , 1995, Neuron.
[38] Eduardo Perozo,et al. Three-dimensional architecture and gating mechanism of a K+ channel studied by EPR spectroscopy , 1998, Nature Structural Biology.
[39] D. Rhodes,et al. Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors. , 1989, Journal of molecular and cellular cardiology.
[40] R. Tsien,et al. Molecular determinants of Ca2+ selectivity and ion permeation in L-type Ca2+ channels , 1993, Nature.
[41] B. Chait,et al. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. , 1998, Science.
[42] N. Klugbauer,et al. Reconstruction of the dihydropyridine site in a non‐L‐type calcium channel: the role of the IS6 segment , 1999, FEBS letters.
[43] S. Siegelbaum,et al. Exposure of Residues in the Cyclic Nucleotide–Gated Channel Pore: P Region Structure and Function in Gating , 1996, Neuron.
[44] S. Goldmann,et al. 1,4‐Dihydropyridines: Effects of Chirality and Conformation on the Calcium Antagonist and Calcium Agonist Activities , 1991 .
[45] Peter Hess,et al. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists , 1984, Nature.
[46] G. Yellen,et al. Gated Access to the Pore of a Voltage-Dependent K+ Channel , 1997, Neuron.
[47] Lori L. Isom,et al. Auxiliary subunits of voltage-gated ion channels , 1994, Neuron.
[48] W. Catterall,et al. Molecular Determinants of High Affinity Dihydropyridine Binding in L-type Calcium Channels (*) , 1996, The Journal of Biological Chemistry.